Actinium Pharmaceuticals Inc (ATNM)vsRevolution Medicines Inc (RVMD)
ATNM
Actinium Pharmaceuticals Inc
$1.40
+6.11%
HEALTHCARE · Cap: $44.02M
RVMD
Revolution Medicines Inc
$203.77
+0.21%
HEALTHCARE · Cap: $44.44B
Smart Verdict
WallStSmart Research — data-driven comparison
Actinium Pharmaceuticals Inc generates 4629% more annual revenue ($35.09M vs $742,000). ATNM leads profitability with a 32.2% profit margin vs 0.0%. ATNM earns a higher WallStSmart Score of 57/100 (C).
ATNM
Buy57
out of 100
Grade: C
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Reasonable price relative to book value
Keeps 32 of every $100 in revenue as profit
Strong operational efficiency at 78.8%
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -167.0% — below average capital efficiency
Trading at 16.8x book value
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : ATNM
The strongest argument for ATNM centers on P/E Ratio, Price/Book, Profit Margin. Profitability is solid with margins at 32.2% and operating margin at 78.8%.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : ATNM
The primary concerns for ATNM are EPS Growth, Market Cap, Piotroski F-Score.
Bear Case : RVMD
The primary concerns for RVMD are Price/Book, EPS Growth, Profit Margin.
Key Dynamics to Monitor
ATNM profiles as a declining stock while RVMD is a value play — different risk/reward profiles.
RVMD carries more volatility with a beta of 1.41 — expect wider price swings.
RVMD is growing revenue faster at -95.2% — sustainability is the question.
ATNM generates stronger free cash flow (-6M), providing more financial flexibility.
Bottom Line
ATNM scores higher overall (57/100 vs 24/100), backed by strong 32.2% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Actinium Pharmaceuticals Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplantation (BMT) or a type of cell therapy, and for other adoptive cell therapies. The company is headquartered in New York, New York.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?